Patent ID: 7906291

Claim:
A method of predicting whether a subject with a First Neurological Event (FNE) will develop relapsing remitting multiple sclerosis (RRMS) or whether a subject with a FNE will develop other neurological disease (OND), the method comprising: providing a blood sample from a subject at FNE; detecting in said blood sample an anti-Glc(α1,4)Glc(α) (GAGA4) IgM isotype antibody and an anti-Glc(α1,6)Glc(α) (GAGA6) IgM isotype antibody; comparing the levels of said antibodies in said blood sample to levels of said antibodies in individuals with OND; and differentiating an FNE subject predicted to develop RRMS from an FNE subject predicted to develop OND by detection of a higher level of said antibodies in said blood sample compared to an OND level of said antibodies.